NCT03995589

Brief Summary

I. To investigate whether patient characteristics, exercise therapy characteristics, local metabolic exercise response, endothelial function, autonomic function or atherosclerotic lesion location can predict the walking response to a successfully completed semi-supervised exercise intervention in patients with intermittent claudication (WP I) II. To assess the effect of a home-based exercise intervention with remote monitoring and coaching on cardiovascular risk factors in patients with intermittent claudication (WP II)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 20, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 24, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

March 8, 2022

Status Verified

March 1, 2022

Enrollment Period

2 years

First QC Date

June 20, 2019

Last Update Submit

March 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain free walking distance

    Treadmill protocol

    Baseline - 12 weeks

Study Arms (2)

Walking Group

EXPERIMENTAL
Other: Walking

Control

ACTIVE COMPARATOR
Other: Control

Interventions

WalkingOTHER

Technology-guided semi-supervised walking therapy

Walking Group
ControlOTHER

Go Home and Walk advice

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \> 17 yrs
  • ABI ≤0.9 and/or 20% decrease after a maximal treadmill test
  • intermittent claudication (Rutherford 1-3)
  • ability to undertake an exercise test and read and understand Dutch questionnaires

You may not qualify if:

  • exercise test induced signs of complex arrhythmias or significant ischemia during baseline testing
  • other comorbidity limiting participation in the exercise group

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KU Leuven

Leuven, 3000, Belgium

Location

Related Publications (1)

  • Cornelis N, Buys R, Fourneau I, Van den Bosch A, De Wilde C, Goetschalckx K, Cornelissen V. Cardiorespiratory fitness in patients with lower extremity artery disease? It takes more than just some steps! Eur J Prev Cardiol. 2022 May 5;29(5):e190-e192. doi: 10.1093/eurjpc/zwab135. No abstract available.

MeSH Terms

Conditions

Peripheral Arterial Disease

Interventions

Walking

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 20, 2019

First Posted

June 24, 2019

Study Start

March 1, 2019

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

March 8, 2022

Record last verified: 2022-03

Locations